Reginaldo Prioli , Ph.D.
Reggie Prioli, Ph.D, Associate Director of Conjugation at Cell Signaling Technology® (CST®), has been conjugating antibodies at CST since 2008. Before CST, he directed the development of ELISA assays for HIV (Immunetics), erythropoietin (Genzyme -FDA approved assay) and aflatoxin (Vicam). Reggie has published over 20 peer reviewed papers. He received his BS in Biology in Brazil, his PhD from University of London and did his post-doc at TUFTS University- New England Medical Center. Reggie is passionate about bioconjugation, resides north of Boston and enjoys skiing. and enjoys skiing.
![[Translate to German:] Cell counts for each biomarker were divided by total number of cells to give a percentage of biomarker positive cells out of total cells for each biomarker.](/fileadmin/_processed_/5/3/csm_Cell_counts_for_biomarkers_with_Cell_DIVE_ee648b397a.jpg "[Translate to German:] Cell counts for each biomarker were divided by total number of cells to give a percentage of biomarker positive cells out of total cells for each biomarker.")
Methoden zur Verbesserung der Reproduzierbarkeit in der räumlichen Biologieforschung
Durch den Einsatz von Automatisierung, hochwertigen Antikörpern und einem bewährten Multiplex-Imaging-Workflow ist Cell DIVE in der Lage, reproduzierbare Ergebnisse zu liefern. In diesem Poster…
Characterizing tumor environment to reveal insights and spatial resolution
Antibodies from Cell Signaling Technology are validated for use with the Cell DIVE multiplexing workflow and used to probe cell lineages in the tumor microenvironment